Summary Between October 1977 and December 1983, 379 consecutive patients have been treated for unilateral, non-metastatic breast cancer, either with conservative (n = 205) or radical surgery (n = 174), with axillary dissection in all the cases. None of them had histologically proved lymph node involvement. Oestrogen receptor (ER) and progesterone receptor (PR) levels were measured on each tumour. Levels > 5 fmol mg-' cytosolic protein were considered as positive for both ER and PR. At 5 years, overall survival (OS) and disease-free survival (DFS) are respectively 88% and 78%. Unifactorial analysis using Kaplan and Meier estimates and the log rank test revealed that OS was significantly related to age (P<0.05), tumour size (P<0.001), histological grading (SBR) (P<0.01), ER (P<0.01) and PR (P<0.001). DFS was significantly related to the same factors. Menopausal status, number of breast tumour foci and previous familial history of breast cancer were not significant. Multifactorial analysis revealed that DFS was significantly related to age (bad prognosis (b.p.) < 37 years old), tumour size and histological grading (b.p. SBR = 3), and that OS was significantly related to tumour size and PR (b.p. PR < 5 fmol mg-' protein). A prognostic score has been constructed for both DFS and OS. These scores divide our patients into three significantly different (P<0.0001) groups with good, intermediate and bad prognosis.
Breast cancer is the most common cause of death from cancer in women. Prognosis is related to different factors including lymph node involvement, hence the better prognosis usually attributed to breast cancer with histologically negative lymph node involvement (N-). For these cancers, however, overall survival and disease-free survival at 5 years range respectively from 73 to 90% and from 60 to 90% (Albano et al., 1979; Bluming et al., 1986; Enquete Permanente Cancer, 1982; Fisher et al., 1969 Fisher et al., , 1983 Henderson, 1987; Nemoto et al., 1980; Sears et al., 1982; Veronesi et al., 1981) . During follow-up, 2-3% N-patients relapse each year (Bulbrook, 1983) . A better knowledge of the factors linked with a bad prognosis would help to isolate high risk sub-groups of N-patients for whom randomised trials may be used to establish optimal therapy.
The purpose of this retrospective study was to try and determine such factors indicating a bad prognosis and to construct a prognostic score based on these prognostic factors to isolate a sub-group of high risk N-patients.
Patients and methods
Between October 1977 and December 1983, 680 consecutive patients were treated at the H. Becquerel Cancer Centre in Rouen for invasive, unilateral, unifocal or multifocal breast cancer. Patients with intraductal carcinoma only were excluded from this study. No visceral or bony metastases were detected on these patients by chest X-ray, bone scintigraphy, hepatic echography or scintigraphy and blood tests. The first therapeutic step was always a surgical operation. Axillary lymph node dissection was performed in every case. An average of 15 nodes per patients (range 2-35) was analysed.
Three hundred and seventy-nine of these patients had no histologically proved lymph node involvement and constitute the basis of this study. The various therapies implemented are detailed in Table I . The average age of the patients at the date of the initial diagnosis was 56 years (range 29-86 years). The main characteristics of the population are detailed in Table II . Surgery was conservative whenever technically possible (size of the tumour compared with breast volume), and this was generally possible for tumours less than 30 mm in diameter, and when the location of the tumour allowed it, although some central tumours have been treated with a tumorectomy. When the treatment was conser- (Table II) . Age of the patients was divided into the following brackets: < 35, 35-40, 41-45 . . 71-75 and >75. Overall survival and disease free survival were examined for each age bracket. Because there was no statistical difference between each age bracket for patients > 37 and < 70, for both disease-free and overall survival, we decided to match these patients together and keep only three age-groups: <37, 38-70, >70 years. The effect of these three age groupings does not disappear over time. Histological grading was tested in its whole in both the univariate and multivariate analyses.
Disease-free interval and overall survival (whatever the cause of death may be) were calculated according to the actuarial method of Kaplan and Meier (1957) . The significance level of differences between curves (P) was determined using the log rank test (Mantel, 1966) . Percentages were compared by x2 analysis. Later, those factors with a prognostic value in the unifactorial analysis were evaluated using Cox's proportional hazards regression model for censored data with a stepwise procedure (Cox, 1972) and for disease-free survival: overall survival, PS = (1.14 x tumour size) -(1.0 x PR); disease-free survival, PS = (0.91 x age) + (0.27 x tumour size) + (0.850 x histological grading). These scores vary between -1.12 and + 2.04 (DFS) and -2.14 and + 1.14 (OS) respectively.
Figures I and 2 show the curves for OS and DFS according to the prognostic score divided into three groups of increasing gravity. The differences between the groups are highly significant (P<0.0001) for both OS and DFS.
Five-year projected disease-free survival rates for the three groups are respectively 92, 77 and 55%, whereas they are 97, 88 and 77% for projected overall survival. The difference between these groups is highly significant (P<0.0001).
Discussion
Why do some N -patients have a poor prognosis? A first explanation may be found in the fact that some of these patients are not truly N-. The group of patients said to have no axillary node involvement in actual fact may include a few women with one or more histologically involved nodes (Trojani et al., 1987) . The accuracy of diagnosis for tumour involvement versus non-involvement increases with the number of nodes studied and with the number of sections studied in a given lymph node (Trojani et al., 1987) . With the immunohistochemical technique using monoclonal antibodies, up to 14% micrometastases can be detected in nodes diagnosed as not involved using conventional histological techniques (Trojani et al., 1987) . The average number of nodes studied in our study is high but only standard techniques of histological assay were used on our patients. Another explanation is that, besides node involvement status, other factors influence prognosis. Statistical analyses including multi-parameter regressions are required to isolate these factors. These analyses give the statistical significance threshold and prognostic weight of each individual factor by taking simultaneously into account the weight of the other factors (Cox, 1972; Locker & Blamey, 1987) . Such information cannot be obtained from univariate analyses. Few multifactorial studies on N -breast cancer have been published (Bauer et al., 1983; Clark & MacGuire, 1986; Dressler et al., 1987; Kallioniemi et al., 1987; Parl et al., 1984; Sears et al., Silvestrini et al., 1986; Thorpe et al., 1987; Trojani et al., 1987; Tubiana et al., 1984) . High nuclear grading (Bauer et al., 1983) , high histological grading (Sears et al., 1982; Stewart et al., 1983; Trojani et al., 1987; Tubiana et al., 1984) , tumour size >5 cm (Clark & MacGuire, 1986; Kallioniemi et al., 1987; Mason et al., 1983; Tubiana et al., 1984) , tumour necrosis (Bauer et al., 1983) , macroscopic invasion of skin by the tumour (Sears et al., 1982) , lymph node hyperplasia (Bauer et al., 1983) , negative oestrogen receptors (Clark & MacGuire, 1986; Mason et al., 1983; Parl et al., 1984) , negative progesterone receptors (Kallioniemi et al., 1987; Mason et al., 1983) are independent prognostic factors that may explain N-breast cancer recurrences reported in the literature. Our results are in line with those already published. In our experience, however, a young age (< 37) has a high individual prognostic weight. This has been described for N-breast cancers studied by univariate analysis only (Adami et al., 1986; Enquete Permanente Cancer, 1982; Host & Lund, 1986) . Age at initial diagnosis, tumour size, histological grading and progesterone receptor status are probably not the only variables that can explain a bad prognosis in N-breast cancers. Shorter disease-free and overall survival have been reported for patients with N-breast cancers having a high tritiated thymidine labelling (LI) index (Silvestrini et al., 1986; Tubiana et al., 1984) . The implementation of this technique is difficult and thus limited to a few centres. Dressler et al. (1987) have stressed the high relapse rate in patients with N-breast cancers with mostly aneuploid cells or with a large fraction in S phase. These two parameters tested in a multivariate analysis have an independent prognostic weight and seem to offer two different prognostic data. These results, however, seem to be controversial at the present time (Kallioniemi et al., 1987; Muss et al., 1986) .
Two factors enabled us to predict shorter overall survival: negative progesterone receptors and large tumour size. Thus, positive progesterone receptors seem to supply by themselves the whole information on the hormonal status of the tumour. This has already been reported both for N+ (Clark et al., 1983) and N-breast cancer (Kallioniemi et al., 1987) , although other teams have reported that positive progesterone receptors do not add any prognostic information when ER status is known (Moot et al., 1987) .
Three independent prognostic factors are predictive of the high risk of recurrence in our population: young age, tumour size >5cm and histological grading 3.
We have constructed a prognostic score both for overall survival and disease-free survival using the significant factors selected by the multivariate analysis. According to these scores, our population is divided into three groups: a high risk group, a medium risk group and a low risk group. The predictive value of the scores, however, is relative to the population studied. It was not possible to validate these scores, for example with the sample test technique, because of the relatively small number of patients available for this test and because of the small number of events observed in our node negative population. Confirmation would require the application of these scores by another team to another population as well as their prospective application.
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